Next generation bioanalytical solutions
- Fill out request form
- Receive, review, and sign NDA
- Review term sheet for license
- Discuss details of license, finalize, sign and pay fees
- Obtain cells under license
Neukopanel® Request Form
for Proprietary Neukoplast® NK-92 Cells
Please complete form to initiate licensing process
THE NK-92® ASSAY COMPANY
Brink Biologics, Inc. (BBI) is a NantKwest Inc. (NASDAQ: NK) affiliated biotechnology solutions company located in the prestigious Torrey Pines biotechnology science park in San Diego, CA.
KILLER CELLS - KILLER ASSAYS™
Natural Killer cell lines originating from a singular source, established in stable cultures under GLP & cGMP conditions and further modified into multiple panels of lines suitable for a range of laboratory testing applications.
NEUKOPANEL® CELL LINES
A standardized panel of CD16 expressing NK-92® cell lines, provides for the first time the means to establish a consistent, robust and reliable assay for assessment of ADCC activity.
Brink Biologics Announces Research License Agreement with Worcester Polytechnic Institute for Use of NantKwest’s NK-92® Cells
NK-92® Cell Based Bioanalytical Solutions are the Key to Optimizing R&D and Commercial Product Development Efforts for Monoclonal Antibodies, Bi-Specifics and Related Biological Products SAN DIEGO--May 1, 2019-- Brink Biologics, Inc., a NantKwest,...
NantKwest Announces New haNK Natural Killer Cell Patent Issuance Further Expanding Intellectual Property Estate
New haNK and T-haNK Based Natural Killer Cell Therapy Programs to Transition to Human Clinical Trials in 2019CULVER CITY, CA - April 1, 2019 - NantKwest (Nasdaq:NK), a leading clinical-stage, natural killer cell based therapeutics company, today announced...
3530 John Hopkins Court
San Diego, CA 92121
8am to 5pm M-F
The content of this website is protected by Title 17 of the U.S. Code and may not be reproduced in whole or in part by any means.